background image

Healthcare Funds

Piper Heartland Healthcare Capital, LLC

Leveraging the industry expertise and capital markets experience of Wall Street's leading healthcare platform

Piper Heartland Healthcare Capital aligns the knowledge, expertise and capital of Piper Sandler with the interests of our limited partnership investors to invest in innovative healthcare companies at key moments in their growth path. This combination—knowledge, expertise, capital and alignment—allows Piper Heartland Healthcare Capital to pursue proprietary investment opportunities and may deliver exception potential returns for investors.

Flagship Fund: The Piper Heartland Healthcare Crossover Fund

The Piper Heartland Healthcare Crossover Fund is a dedicated healthcare investment platform with over $200 million in committed capital, that focuses on innovative companies with near-term public markets prospects, driven by experienced management teams and backed by highly respected investment partners.

Building on the industry knowledge and capital markets expertise of Piper Sandler’s leading healthcare banking and research platforms, the Piper Heartland Healthcare Crossover Fund invests primarily in biotech, med-tech and healthcare information sectors.

Read the press release announcing the final closing of the fund.

FW - Healthcare 1


Bookrun public equity financings representing over $40 billion in capital*



Companies covered across all major healthcare subsectors by 12 senior research analysts

Piper Sandler Healthcare Platform

Piper Sandler & Co. has been a leading strategic adviser in healthcare investment banking and underwriting for over 30 years. In addition to strategic and capital advisory services, Piper Sandler serves clients through an award-winning research platform, which publishes macro-economic, industry and company-specific research.

*As of 2010, healthcare companies


Target Investment Characteristics

Healthcare Industry Focus: Healthcare companies within Piper Sandler’s established areas of advisory expertise and research coverage

Late-Stage and Crossover Focus: Last round of private investment for companies that have near or mid-term potential liquidity paths available to them

Differentiated Technologies or Services: Healthcare companies that possess technology, IP, processes, know-how or other proprietary attributes that are innovative and disruptive

Strong Management: Talented management teams capable of executing clinical, development and business plans while adapting to anticipated and unanticipated challenges

Respected Investor Syndicates: Highly respected managers that have an exceptional record of investing in sector-specific healthcare companies in both private and public equity opportunities

Aligned Perspective: Aligned with Piper Sandler investment banking, equity research and capital markets – to ensure a unified perspective of market potential for the technology or service offerings from our target portfolio investments

Current and Past Investments

Since inception, Piper Heartland Healthcare Capital has invested in the following companies:

BicaraBoundless BioCargoCleerly